SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-24-011824
Filing Date
2024-02-08
Accepted
2024-02-08 06:02:46
Documents
2
Group Members
PITANGO H.T. FUND I, L.P.PITANGO HEALTHTECH FUND I - ISRAEL L.P.PITANGO HEALTHTECH PRINCIPALS FUND I, L .P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245444d1_sc13ga.htm SC 13G/A 90407
2 EXHIBIT 1 tm245444d1_ex-1.htm EX-99.1 13221
  Complete submission text file 0001104659-24-011824.txt   105363
Mailing Address 11 HAMENOFIM STREET BUILDING B HERZLIYA L3 46725
Business Address 11 HAMENOFIM STREET BUILDING B HERZLIYA L3 46725 97299718100
Pitango HealthTech Fund I, L.P. (Filed by) CIK: 0001775340 (see all company filings)

IRS No.: 981485171 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Subject) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92700 | Film No.: 24606694
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)